ArticleNeuro-oncology2020

Comments on: "Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity".

Olaf van Tellingen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.